Lista de obras - Francisco Barrera - Dominio Público Uruguay

Accuracy of the BAR score in the prediction of survival after liver transplantation

artículo científico publicado en 2019

Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis

artículo científico publicado en 2017

Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis

artículo científico publicado en 2014

Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort

scientific article published on 08 January 2020

Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis.

artículo científico publicado en 2015

Bile Acids and Portal Hypertension

artículo científico publicado en 2017

Chemical hypoxia induces pro-inflammatory signals in fat-laden hepatocytes and contributes to cellular crosstalk with Kupffer cells through extracellular vesicles

scientific article published on 29 February 2020

Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations

artículo científico publicado en 2019

Conversion to mycophenolate mofetil monotherapy in liver recipients: Calcineurin inhibitor levels are key

artículo científico publicado en 2017

Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1.

artículo científico publicado en 2016

Effect of Hepatitis B virus on Steatosis in Hepatitis C virus co-infected subjects: a multi-center study and systematic review

artículo científico publicado en 2018

Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19.

artículo científico publicado en 2015

First Report of Living Donor Liver Transplantation for Imatinib-Resistant GIST Liver Metastases. A new therapeutic option in Transplant Oncology

scientific article published on 04 April 2020

High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients

article published in 2016

Is flumazenil an alternative for the treatment of hepatic encephalopathy?

artículo científico publicado en 2017

Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients

artículo científico publicado en 2015

Mycobacterium abscessus pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin.

artículo científico publicado en 2015

NON-ALCOHOLIC FATTY LIVER DISEASE AND SARCOPENIA: PATHOPHYSIOLOGICAL CONNECTIONS AND THERAPEUTIC IMPLICATIONS

artículo científico publicado en 2020

Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship

artículo científico publicado en 2017

Obeticholic acid: expanding the therapeutic landscape of NASH.

artículo científico

Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis C.

artículo científico publicado en 2012

Pathophysiological connections between gallstone disease, insulin resistance, and obesity

scientific article published on 08 December 2019

Platelet count/spleen diameter ratio for non-invasive prediction of high risk esophageal varices in cirrhotic patients.

artículo científico publicado en 2009

Prediction of Esophageal Variceal Bleeding in Liver Cirrhosis: Is There a Role for Hemostatic Factors?

artículo científico

Prothrombotic factors and nonalcoholic fatty liver disease: an additional link to cardiovascular risk?

artículo científico publicado en 2013

Quantification of visceral adipose tissue using magnetic resonance imaging compared with anthropometry, in type 2 diabetic patients

artículo científico publicado en 2012

Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.

artículo científico publicado en 2017

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease

scientific article published on 13 July 2013

Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.

artículo científico publicado en 2014

Somatotropic Axis Dysfunction in Non-Alcoholic Fatty Liver Disease: Beneficial Hepatic and Systemic Effects of Hormone Supplementation.

artículo científico publicado en 2018

Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study.

artículo científico publicado en 2017

The Evolving Role of Liver Biopsy in Non-alcoholic Fatty Liver Disease

scientific article published on 01 October 2018

The L-α-lysophosphatidylinositol/GPR55 system induces the development of non-alcoholic steatosis and steatohepatitis

artículo científico publicado en 2020

The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease.

artículo científico publicado en 2016

The role of diet and nutritional intervention for the management of patients with NAFLD.

artículo científico

[Direct antivirals for the treatment of chronic hepatitis C virus infection. Experience in 106 patients].

artículo científico publicado en 2017

[Liver transplantation in a patient with human immunodeficiency virus (HIV). Case report]

scientific article published on 01 December 2018

Lista de obras de Francisco Barrera

Accuracy of the BAR score in the prediction of survival after liver transplantation

Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis

Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis

Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort

Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis.

Bile Acids and Portal Hypertension

Chemical hypoxia induces pro-inflammatory signals in fat-laden hepatocytes and contributes to cellular crosstalk with Kupffer cells through extracellular vesicles

Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations

Conversion to mycophenolate mofetil monotherapy in liver recipients: Calcineurin inhibitor levels are key

Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1.

Effect of Hepatitis B virus on Steatosis in Hepatitis C virus co-infected subjects: a multi-center study and systematic review

Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19.

First Report of Living Donor Liver Transplantation for Imatinib-Resistant GIST Liver Metastases. A new therapeutic option in Transplant Oncology

High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients

Is flumazenil an alternative for the treatment of hepatic encephalopathy?

Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients

Mycobacterium abscessus pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirin.

NON-ALCOHOLIC FATTY LIVER DISEASE AND SARCOPENIA: PATHOPHYSIOLOGICAL CONNECTIONS AND THERAPEUTIC IMPLICATIONS

Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship

Obeticholic acid: expanding the therapeutic landscape of NASH.

Oxidative stress is closely associated with insulin resistance in genotypes 1 and 3 chronic hepatitis C.

Pathophysiological connections between gallstone disease, insulin resistance, and obesity

Platelet count/spleen diameter ratio for non-invasive prediction of high risk esophageal varices in cirrhotic patients.

Prediction of Esophageal Variceal Bleeding in Liver Cirrhosis: Is There a Role for Hemostatic Factors?

Prothrombotic factors and nonalcoholic fatty liver disease: an additional link to cardiovascular risk?

Quantification of visceral adipose tissue using magnetic resonance imaging compared with anthropometry, in type 2 diabetic patients

Serum cytokeratin-18 fragment levels as noninvasive marker of nonalcoholic steatohepatitis in the chilean population.

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease

Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.

Somatotropic Axis Dysfunction in Non-Alcoholic Fatty Liver Disease: Beneficial Hepatic and Systemic Effects of Hormone Supplementation.

Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study.

The Evolving Role of Liver Biopsy in Non-alcoholic Fatty Liver Disease

The L-α-lysophosphatidylinositol/GPR55 system induces the development of non-alcoholic steatosis and steatohepatitis

The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease.

The role of diet and nutritional intervention for the management of patients with NAFLD.

[Direct antivirals for the treatment of chronic hepatitis C virus infection. Experience in 106 patients].

[Liver transplantation in a patient with human immunodeficiency virus (HIV). Case report]